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Abstract
We describe a method for the highly efficient and precise targeted modification of gene trap loci 
in mouse embryonic stem cells (ESCs). Through the Floxin method, gene trap mutations are 
reverted and new DNA sequences inserted using Cre recombinase and a shuttle vector, pFloxin. 
Floxin technology is applicable to the existing collection of 24,149 compatible gene trap cell lines, 
which should enable the high-throughput modification of many genes in mouse ESCs.
Genetic modification of mice and of embryonic stem cells (ESCs) is an important source of 
insight into the functions of vertebrate genes. Current methods commonly used for 
genetically modifying ESCs are transgene insertion and homologous recombination. 
Transgene insertion involves integration at a random location in the genome. Homologous 
recombination can create targeted mutations, but only about 1.5% of ESC clones, on 
average, correctly integrate the construct and different targeting constructs must be created 
for each gene.
A complementary approach to generating loss-of-function mutations in ESCs is gene 
trapping1–3. Below, we describe the gene trap vectors pGTLxf and pGTLxr, which allow 
post-insertional modification of the trapped locus using an accompanying technology called 
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AOP: An efficient system for the reversion and modification of mouse gene trap alleles is presented. It is applicable to available 
collections of gene trap embryonic stem cell lines.
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collections of gene trap embryonic stem cell lines.
HHS Public Access
Author manuscript
Nat Methods. Author manuscript; available in PMC 2010 July 01.
Published in final edited form as:
Nat Methods. 2010 January ; 7(1): 50–52. doi:10.1038/nmeth.1406.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Floxin (Flanked lox site insertion), based on recombination mediated cassette exchange 
(RMCE).
We show a schematic of mutation, reversion, and modification of a generic, autosomal Your 
Favorite Gene (YFG) (Fig. 1a–d). A pGTLxf or pGTLxr gene trap in an intron of YFG 
results in expression of a YFG-βgeo fusion protein in the gene trap line YFGGt/+ (Fig. 1a). 
To revert this loss-of-function mutation, transiently expressed Cre excises the floxed splice 
acceptor, leaving a single Lox71 site (Fig. 1b)4. In the absence of the splice acceptor, 
YFGRev/+ cells lose βgeo expression and reactivate YFG expression.
To permit modification of a gene trap locus, pFloxin vectors contain a Lox66 site (Fig. 1c) 
so that Cre-mediated recombination between the pFloxin Lox66 and the genomic Lox71 site 
of revertant cells results in directional insertion of the pFloxin sequence (Fig. 1d). 
Recombination between Lox66 and Lox71 sites produces one inactive Lox site and one 
LoxP site (Fig. 1d), making this integration irreversible5.
Floxin vectors also permit expression of defined sequences at the modified locus (Fig. 1c–
d). Although Floxin can facilitate many kinds of gene modifications, we illustrate here the 
production of carboxy- and amino-terminally tagged alleles of YFG. The pFloxin-YFG-Flag 
inserted cDNA is spliced so that the inserted sequence is expressed as a fusion with 
upstream exons from the endogenous promoter. The other Floxin vector, pFloxin-IRES-HA-
YFG, contains an IRES element to initiate translation of an amino-terminally tagged version 
of YFG. The line YFGIRES-HA-YFG/+ expresses full length HA-YFG under the control of the 
endogenous promoter and the IRES element. The Floxin vectors also include βActin 
promoters that reactivate βgeo expression and thus permit pharmacological selection of 
correct insertions (Fig. 1c–d).
RMCE has been shown previously to function robustly in ESCs with varied vector 
designs6–11. To date, the BayGenomics and Sanger Institute gene trap efforts have 
generated 24,149 gene trap cell lines with the pGTLxf and pGTLxr vectors, representing 
4,528 individual genes12. A list of the gene trap alleles is reported here (Supplementary 
Table 1), and the cell lines are available to the community through the International Gene 
Trap Consortium (IGTC) database (www.genetrap.org).
Here, we demonstrate modification of eight genomic loci (Sall4, Suz12, Ofd1, Gli2, Tardbp, 
Sntb2, Pex14 and Tet1) using gene trap cell lines and the Floxin system. We note that 
Ofd1Gt (Ofd1Gt(RRF427)Byg; MGI names for all alleles are provided in Supplementary Table 
2) cells are hemizygous as the Ofd1 gene is X-linked and the E14 gene trap ESCs are male. 
Consequently, Ofd1Gt cells do not produce any Ofd1 protein (Fig. 1e).
To remove the exogenous splice acceptor, we electroporated gene trap cells with an 
expression construct for nuclear Cre recombinase. On average, 45% of colonies screened 
showed proper excision of the splice acceptor (Table 1). Revertant cells no longer displayed 
β-galactosidase activity or neomycin resistance (Fig. 2a, Supplementary Fig. 1d), and 
reversion caused loss of the βgeo transcript (Supplementary Fig. 1e). Genomic PCR and 
Southern blot confirmed correct excision of the splice acceptor in revertant cells 
(Supplementary Fig. 1f–g).
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Using the Floxin strategy, we generated cell lines expressing wild type Ofd1, Suz12, Sall4, 
Gli2, or Tardbp with carboxy-terminal tags, and lines expressing eGFP at the Sntb2, Pex14, 
or Tet1 genomic loci. Revertant lines were co-electroporated with the appropriate pFloxin or 
pFloxin-IRES construct and a nuclear Cre expression construct and selected with neomycin. 
On average, 86% of resultant ESC colonies contained the correctly integrated pFloxin 
construct (Table 2), and β-galactosidase activity was re-activated (Fig. 2a). Genomic PCR 
and Southern blot confirmed integration in Floxin cell lines (Supplementary Fig. 1g, 
Supplementary Fig. 2a–c). These data indicate that Floxin-mediated targeted insertion 
occurs efficiently and accurately in many different genomic contexts.
Quantitative RT-PCR and immunoblot indicated that revertant alleles are expressed at wild 
type levels in Sall4Rev/+ and Suz12Rev/+(Fig. 2b and Supplementary Fig. 2d). In contrast, 
Ofd1Rev cells expressed lower levels of Ofd1 (at the expected size of 110 kD) than wild type 
cells (Fig. 2c). Ofd1 is essential for the formation of the primary cilium13, and wild type 
ESCs possess primary cilia whereas Ofd1Gt cells do not. However, Ofd1Rev cells possessed 
primary cilia, indicating that reversion of the gene trap mutation restored gene function (Fig. 
2d). RT-PCR and sequencing indicated that the reduced Ofd1 expression is attributable to 
the use of cryptic splice acceptor sites present in the βgeo cassette (data not shown). 
Moreover, the βgeo transcript is detectable by Northern blot in a subset of revertant lines 
(Supplementary Fig. 1e). The use of these cryptic splice acceptor sites in certain revertant 
cell lines suggests that locus-dependent factors affect the restoration of normal expression.
Floxin-inserted alleles were expressed at levels equivalent to the revertant alleles. The 
tagged alleles for both Sall4Sall4TAP/+ and Suz12Suz12TAP/+ were expressed at wild type 
levels (Fig. 2b and Supplementary Fig. 2d). Although Ofd1-Myc protein levels were lower 
than that of wild type (Fig. 2c), production of Ofd1-Myc was also sufficient to support 
ciliogenesis (Fig. 2e) and Ofd1-Myc, like endogenous Ofd1, localized to the centrosome 
(Fig. 2f). Suz12-TAP, like endogenous Suz12, localized to the nucleus (Fig. 2g), and ESC 
differentiation led to downregulation of endogenous Suz12 and Suz12-TAP to similar 
extents (Fig. 2h)14. Together, these data indicate that Floxin cells produce modified proteins 
that function and are regulated similar to wild type proteins.
In addition to tagged versions of endogenous genes, the Floxin technology can insert 
exogenous DNA into loci. Sntb2IRESeGFP/+, Pex14IRESeGFP/+ and Tet1IRESeGFP/+ lines 
expressed eGFP under the control of endogenous regulatory elements (Supplementary Fig. 
2e).
The presence of vector sequences may affect normal gene expression15. Therefore, we 
included Frt sites in the gene trap and Floxin vectors to allow for Flp-mediated removal of 
the βActin promoter and βgeo cassette (Supplementary Fig. 3a). We electroporated 
Ofd1Ofd1myc or Gli2Gli2TAP/+ cells with a FLPo expression construct16 and identified cells in 
which the βActin-βgeo cassette was successfully excised by loss of β-galactosidase activity 
(Fig. 2a). Genomic PCR verified correct excision (Supplementary Fig. 3c). Removal of 
vector sequences increased the expression of Ofd1-Myc (Supplementary Fig. 3d).
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To assess whether the genetic manipulations associated with gene trapping, reversion, and 
the Floxin process affected ESCs, we performed karyotyping and evaluated pluripotency by 
three methods. The five Floxin lines evaluated showed normal euploid karyotypes (data not 
shown). All Floxin lines had normal ES colony and cell morphology (Supplementary Fig. 
4a). Additionally, Floxin lines had expression levels similar to wild type ESCs for three 
regulators of pluripotency, Oct4, Sox2 and Nanog (Supplementary Fig. 4b), and could 
differentiate into cell types that express Fgf5, Afp and T/Brachyury, markers of embryonic 
ectoderm, endoderm and mesoderm, respectively (Supplementary Fig. 4c). While these 
assays suggest that the Floxin process does not adversely affect ESC pluripotency, germline 
competency of Floxin cells has not been systematically evaluated. Other studies have shown 
that three genetic manipulations do not necessarily limit germline transmission7, 17.
A detailed understanding of gene function requires the generation of a range of alleles. The 
Floxin strategy described here allows for high throughput modification of ESC loci 
harboring insertions of the pGTLxf or pGTLxr gene trap vectors. The Floxin system allows 
for Cre-mediated reversion of the gene trap mutation and subsequent insertion of new DNA 
of interest into the genomic locus. Genes of interest are cloned with standard molecular 
biology techniques into pFloxin shuttle vectors. With each manipulation, the presence or 
absence of βgeo expression assists in the selection or identification of the desired cells.
We have demonstrated the generation of tagged or reporter alleles at eight loci, and shown 
how the technology can be used to model a human genetic disease in ESCs, study protein 
localization, and report on the dynamics of protein expression (Supplementary Table 3). The 
gene trap allele can also be converted into a wide variety of other tailored alleles, such as 
missense, deletion, and domain swap alleles, and Floxin can be used to insert non-
homologous DNA sequences into endogenous loci. This approach could be utilized for 
generating alleles expressing other exogenous proteins such as Cre, rtTA, ΦC31 integrase, 
Alkaline phosphatase, or Diptheria toxin under the control of tissue- or cell type-specific 
promoters.
The Floxin strategy has several advantages over previously described approaches for 
recombinase-mediated insertion of exogenous DNA elements6–8, 10. First, reversion allows 
for confirmation that observed cellular phenotypes are due to the gene trap mutation, as 
demonstrated for the role of Ofd1 in ciliogenesis. Second, inserted DNA sequences can be 
expressed either as a direct fusion to upstream exons, or as a separate cistron. Third, Frt sites 
allow for removal of the βActin-βgeo cassette, abrogating interference from vector 
prokaryotic sequences. Lastly, the Floxin technology is compatible with the extensive 
collection of 24,149 characterized and validated gene trap lines available to the community.
The Floxin strategy of reversion and new DNA insertion are both highly efficient and 
reproducible at a variety of loci. By avoiding the most laborious aspects of traditional gene 
replacement strategies, the Floxin system allows new alleles to be engineered with minimal 
effort.
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MATERIALS AND METHODS
Cell Lines and Cell Culture
Ofd1Gt (RRF427), Sall4Gt/+(XE027), Suz12Gt/+(XG122), Gli2Gt/+ (XG045), and TardbpGt/+ 
(RRB030) E14 ESC lines were obtained from BayGenomics. Sntb2Gt/+ (XC195), Pex14Gt/+ 
(XC197), Tet1Gt/+ (XD006), FlnaGt (XC373), Btf3Gt/+ (XD028), Nsd1Gt/+ (XC030), and 
XD052Gt (XD052) were provided by W.C.S. Cells were cultured on 0.1% gelatin in GMEM 
supplemented with 10% FBS, glutamine, pyruvate, NEAA, βME, and LIF.
Plasmids and Vector Construction
pPGK-NLS-Cre expresses a fusion of the bacteriophage P1 recombinase Cre with a SV40 
large T antigen nuclear localization signal18. pFloxin vectors were built from the 
pBluescript backbone by PCR amplification and insertion of an Engrailed2 splice acceptor 
sequence, SV40 polyA signal and, in the case of pFloxin-IRES, an IRES. The tandem stop 
codons and multiple cloning site polylinker were synthesized as oligonucleotides and ligated 
into the vectors. All pFloxin constructs were produced in recA1 Stbl2 cells (Invitrogen) 
according to manufacturer’s protocol, except cultures were grown at 37° in LB medium. 
GenBank accession numbers for pFloxin, pFloxin-IRES, pFloxin-TAP, and pFloxin-IRES-
eGFP are EU916834, EU916835, EU916836, and GQ357182 respectively. The vector 
pFloxin-MCS2-IRES-MCS (GenBank number GU180239) with two multiple cloning sites 
and an IRES allows insertion of homologous cDNA as well as a reporter regulated by the 
same promoter.
cDNA constructs and cloning
Suz12 and Sall4 cDNAs were gifts from Miguel Ramalho-Santos. To make Sall4Sall4TAP/+ 
and Suz12Suz12TAP/+ cell lines, primers were used to amplify and add appropriate restriction 
sites to exons 2–4 of Sall4, and exons 8–16 of Suz12 (Supplementary Table 4). The cDNAs 
were then cloned into pFloxin-TAP, in frame with the TAP tag. Ofd1 cDNA was cloned 
from RNA of E11.5 mouse embryos using 1 Step RT-PCR kit (Invitrogen). Further 
amplification and addition of the Myc tag was performed with the Expand High Fidelity kit 
(Roche). Quik Change II XL site directed mutagenesis kit (Stratagene) was used to repair 
missense mutations introduced during PCR. Final products were confirmed by sequencing.
Electroporation and Selection
For reversion: 60 µg of pGK-NLS-Cre DNA was ethanol precipitated, and the pellet washed 
3 times with 70% ethanol. The pellet was dried in tissue culture hood for 30’ at room 
temperature and resuspended in 100 µl calcium-magnesium free PBS overnight at room 
temperature. On the morning of electroporation, new media was added to the gene trap cells 
grown to 70–90% confluency in a T75 flask. After 3–4 hours, cells were trypsinized, 
counted, and washed with PBS. 107 cells were added to a chilled electroporation cuvette 
with DNA and electroporated at 240 V, 500 µF, exponential (Bio-Rad GenePulser Xcell). 
Electroporated cells were incubated 20’ at room temperature, and 105 cells were split evenly 
between 10 10-cm plates. Colonies were picked and transferred to a 48 well plate after 3–5 
days.
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For Floxin: pGK-NLS-Cre and pFloxin DNA were prepared as above. We electroporated 
revertant cell lines with both DNAs as above, except 107 cells were plated evenly between 6 
10-cm plates. We began selection with 150–350 µg/ml G418 (Invitrogen) one day after 
electroporation, and picked colonies after 6–7 days.
For FLP removal of vector sequence: 120 µg pPGK-FLPo (Addgene plasmid 13793) was 
prepared as above16. We electroporated and plated Floxin cell lines as described in the 
reversion section above.
β-galactosidase Activity Assays
Galacto-Light Plus System (Applied Biosystems) was used to assay cell lysates from a 24 or 
48-well plate according to manufacturer’s protocol.
Quantitative PCR
RNA was extracted from ESCs or embryoid bodies using RNeasy Plus (Qiagen). First strand 
cDNA synthesis was performed using extracted RNA with iScript (Biorad) or First Strand 
cDNA Synthesis (Fermentas). Transcript levels were measured in triplicate using a 7300 
Real-time PCR machine (Applied Biosystems) and then normalized to βActin levels.
Antibodies
Antibodies to Ofd1 were generated by Covance by immunizing rabbits with the peptide [H]-
CDTYDQKLKTELLKYQLELKDDYI–[NH2] corresponding to amino acids 340–362 of 
murine Ofd1. Antibody was used at 1:5000 for Western blotting and 9.2 µg for IP. Other 
antibodies used were: acetylated Tubulin (Sigma T6793) used at 1:1000, γ–Tubulin (Santa 
Cruz sc-7396) 1:200, GFP (Aves Labs GFP-1020) 1:500, Centrin1 (Abcam ab11257) 1:200, 
Suz12 (Santa Cruz sc-46264) 1:200, Flag (Sigma F7425) 1:500 for IF. Flag resin (Sigma) 
was used for IP. Myc antibody (Novus Biologicals NB600-335) was used at 1:1000 for 
immunoblotting, 1:200 for IF, and 3 µg for IP. TAP antibody (GenScript A00683) was used 
at 1:500 for immunoblotting. Secondary antibodies were conjugated with Alexa Fluor 488 or 
555 (Invitrogen) and used at 1:400.
Immunofluorescence and Microscopy
For ESC ciliation studies: ESCs were plated on coverslips coated with poly-D-lysine and 1% 
Matrigel (BD) and treated with 0.5 mM mimosine (Sigma) overnight to arrest cells. Cells 
were fixed 5’ in 4% PFA, washed in PBS, and fixed 2–3’ in −20° methanol. The cells were 
then washed in PBS with 0.1% Triton-X100 (PBST), blocked in 2% BSA in PBST, and 
incubated with primary antibodies in block for 1 hr at RT. The cells were washed in PBST, 
incubated with secondary antibodies in block for 30’ at RT, and mounted with Vectashield 
hardset with DAPI (Vector labs). Slides were viewed on Deltavision microscope (Applied 
Precision) and images were processed with Deltavision and Metamorph (Molecular 
Devices) software.
For GFP staining: Cells were plated on coverslips as above and cultured overnight. Cells 
were fixed 5’ in 4% PFA and stained as above. Slides were viewed on an Axio Observer D1 
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(Zeiss) microscope and images were processed with Axiovision (Zeiss), ImageJ (NIH), and 
Metamorph (Molecular Devices) software.
For TAP staining: Cells were plated on coverslips as above and cultured overnight. The cells 
were fixed in 100% methanol for 5’and stained as above. Slides were viewed on Nikon C1 
confocal and images were processed with Nikon EZ-C1 software.
For cellular morphology assessment: Cells were plated in 6 well plates and viewed on an 
Axio Observer D1 (Zeiss) microscope.
ESC differentiation
ESCs were plated in suspension culture in ultra-low adherence six well plates (Corning) at 
5×105 per well (differentiation assay to asses Suz12 expression) or 106 per well in duplicate 
(pluripotency assessment) to induce embryoid body formation. Suspension media consisted 
of 10% FBS, nonessential amino acids, pyruvate, glutamine, and βME in GMEM and was 
changed every other day. For the differentiation assay to assess Suz12 expression, protein 
lysate was collected on 0, 4, 8, and 12 days following initial plating. For pluripotency 
assessment, RNA was collected 7 days after plating.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. The Floxin strategy for reversion and modification of gene trap loci
(a) In the wild type allele of Your Favorite Gene (YFG), exons 1 and 2 are spliced together 
and translated to produce full length YFG protein. In the gene trap line of genotype YFGGt/+, 
a splice acceptor (yellow box) flanked by Lox71 and LoxP sites co-opts splicing to create a 
fusion between βgeo and the 5’ endogenous exon. βgeo encodes a fusion of β-galactosidase 
and neomycin resistance. (b) Reversion of the gene trap mutation to yield revertant line 
YFGRev (genotype YFPRev/+). Cre recombines the Lox71 and LoxP sites, restoring 
endogenous splicing and wild type expression of YFG. (c) Vectors for Floxin-mediated 
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cassette insertion. Cre recombines the genomic Lox71 and Floxin Lox66 sites to integrate 
the pFloxin construct into the genomic locus. In these examples, Floxin mediates insertion 
of exon 2 of YFG with a C-terminal Flag tag (left) or the full-length cDNA for YFG with an 
N-terminal HA tag (right). (d) Schematic showing Floxin alleles that express tagged YFG 
under the control of endogenous regulatory elements and re-express βgeo. (e) Immunoblots 
with the indicated antibodies ESCs of the Ofd1Gt genotype. 10 µg protein per lane.
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Figure 2. Efficient reversion of gene trap mutations and Floxin-mediated engineering of new 
alleles
(a) Plot of β-galactosidase activity in cell lines of the indicated genotypes. Error bars are 
standard deviations from 1–4 different experiments with a minimum of 3 replicates each. (b) 
Immunoblot showing Suz12 (left and middle panels, 20 µg protein per lane) and Sall4 (right 
panel, immunoprecipitated from 500 µg total protein for each cell line) protein levels in the 
cell lines of the indicated genotypes. (c) Immunoblots showing expression of full length 
Myc-tagged Ofd1 (left panel, 25 µg protein per lane; right panel, immunoprecipitate from 
800 µg total protein for each cell line), and of Ofd1 in Ofd1Rev cells (middle panel, 
immunoprecipitate from 4 mg total protein for each cell line). (d, e) Representative 
fluorescence micrographs of cell lines of the indicated genotypes. Cilia (acetylated Tubulin, 
green), centrosomes (γ-Tubulin, red), DNA (DAPI, blue). (f) Representative fluorescence 
micrograph of Ofd1-Myc localization. Ofd1 (Myc, green), centrosome (Centrin, red), DNA 
(DAPI, blue). (g) Representative fluorescence micrograph of Suz12-TAP localization. 
Suz12 (Flag, green), centrosome (Acetylated Tubulin, red), DNA (DAPI, blue). (h) 
Immunoblot showing wild type Suz12 and Suz12-TAP protein downregulation upon 
differentiation of Suz12Suz12TAP/+ cells. 3 µg protein per lane. Scale bars 5 µm, with 
magnified inset scale bar 1 µm.
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Table 1
Cell Line % with correct reversion Chromosome
Ofd1Rev 62 X
Sall4Rev/+ 45 2
Suz12Rev/+ 74 11
Gli2Rev/+ 74 1
TardbpRev/+ 33 4
Sntb2Rev/+ 27 8
Pex14Rev/+ 24 4
Tet1Rev/+ 18 10
Average 45
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Table 2
Cell Line % with correct Floxin
Ofd1IRESOf1myc 92
Ofd1Of1myc 73
Sall4Sall4TAP/+ 89
Suz12Suz12TAP/+ 91
Gli2Gli2TAP/+ 88
TardbpTardbpTAP/+ 68
Sntb2IRESeGFP/+ 100
Pex14IRESeGFP/+ 89
Tet1IRESeGFP/+ 80
Average 86
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